Facebook
Twitter
LinkedIn
ForwardPulse - Doubling After CABG? Dual Antiplatelet Therapy after Coronary Artery Bypass Grafting
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
This educational activity aims to discuss the use of dual antiplatelet therapy after coronary artery bypass grafting surgery and patient specific factors that can effect decision making.
Target Audience
Pharmacist
Learning Objectives
1. Describe coronary artery bypass grafting and current guideline recommendations
2. Discuss evidence for dual antiplatelet therapy after coronary artery bypass grafting
3. Explain dual antiplatelet strategies and patient specific factors that influence decision-making
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_14.pptx | 460.17 KB |
 6-14-23 pulse.docx | 16.2 KB |
 Tober PULSE 2 Handout.pdf | 358.97 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
This educational activity aims to discuss the use of dual antiplatelet therapy after coronary artery bypass grafting surgery and patient specific factors that can effect decision making.
Ryan Tober, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.